The role of pathogen-reduced platelet transfusions on HLA alloimmunization in hemato-oncological patients.
Anno SarisJean Louis KerkhoffsPhillip J NorrisS Marieke van HamAnja Ten BrinkeAnneke BrandPieter F van der MeerJaap Jan ZwagingaPublished in: Transfusion (2018)
Our data clearly indicate that Mirasol pathogen inactivation does not prevent HLA Class I or II alloimmunization after platelet transfusions.